Turmeric Could Reduce Breast Cancer Risk in Women Exposed to HRT

Studies have found that postmenopausal women who have taken a combined estrogen and progestin hormone replacement therapy (HRT) have increased their risk of developing progestin-accelerated breast cancer tumors. Researchers have now found that curcumin, a popular Indian spice derived from the turmeric root, could reduce breast cancer risk for women after exposure to HRT.

"Approximately 6 million women in the United States use HRT to treat the symptoms of menopause," said Salman Hyder, study author. "This exposure to progestin will predispose a large number of post-menopausal women to future development of breast cancer. The results of our study show that women could potentially take curcumin to protect themselves from developing progestin-accelerated breast cancer tumors."

The researchers found that curcumin delayed the first appearance, decreased incidence and reduced multiplicity of progestin-accelerated breast cancer tumors in an animal model. Curcumin also prevented the appearance of gross morphological abnormalities in the mammary glands.

In previous studies, researchers showed that progestin accelerated the development of certain tumors by increasing production of a molecule called VEGF that helps supply blood to the tumor. By blocking the production of VEGF, researchers could potentially reduce the proliferation of breast cancer cells. Curcumin inhibits progestin-induced VEGF secretion from breast cancer cells, Hyder said.

"Curcumin and other potential anti-angiogenic compounds should be tested further as dietary chemopreventive agents in women already exposed to hormone replacement therapy containing estrogen and progestin in an effort to decrease or delay the risk of breast cancer associated with combined hormone replacement therapy," Hyder said.

Related Articles

Chlordecone Exposure Associated With Increased Risk of Prostate Cancer

Research shows that exposure to chlordecone (also named Kepone), an organochlorine chemical with well defined estrogenic properties used in the French West Indies until 1993, is associated with

Soy for Prostate Cancer, But What About Possible Unwanted Effects?

It’s no wonder that men who have read the recent stories circulating about soy are confused. Some stories claim that soy foods, such as tofu and soy milk, can lead

An Increase in Leptin Could Promote Colorectal Cancer

While researchers have known that obesity increases the risk for the development of colon cancer, the underlying molecular mechanisms have remained unclear. Now, for

Size of Tumors in Prostate Cancer Patients Directly Linked to Weight

The size of tumors in prostate cancer patients is directly linked to their weight, according to a new six-year study. The research team, led by Nilesh Patil, found heavier patients, or those

Study Suggests Calcium Associated with Lower Risk of Cancer

According to a report in the Archives of Internal Medicine, women with higher intake of calcium appear to have a lower risk of cancer overall, and both men and women

References:
1. Salman Hyder, et al. Curcumin delays development of MPA-accelerated DMBA-induced mammary tumors. Menopause, a journal of the North American Menopause Society.